Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study Article

Industry Collaboration International Collaboration

author list

  • Faivre, S.; Niccoli, P.; Castellano, D.; Valle, J. W.; Hammel, P.; Raoul, J. -L.; Vinik, A.; Van Cutsem, E.; Bang, Y. -J.; Lee, S. -H.; Borbath, I.; Lombard-Bohas, C.; Metrakos, P.; Smith, D.; Chen, J. -S.; Ruszniewski, P.; Seitz, J. -F.; Patyna, S.; Lu, D. R.; Ishak, K. J.; Raymond, E.

authors

publication date

  • 2017

webpage

published in

category

keywords

  • VEGFR inhibitor
  • antiangiogenics
  • blinded independent central review
  • crossover
  • rank-preserving structural failure time (RPSFT)

start page

  • 339

end page

  • 343

volume

  • 28

issue

  • 2